Cat. No.: X23-10-ZQ607
CXCR inhibitor AMD-070 HCl, Purity ≥98%
Synonym: 880549-30-4; AMD-070 hydrochloride; Mavorixafor HCl; (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine hydrochloride; N'-(1H-Benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine hydrochloride; Mavorixafor hydrochloride; N'-(1H-Benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine; CXCR inhibitor
- MDL: MFCD23160058
- CAS Number: 880549-30-4
- Compound CID: 71576687
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
AMD-070 HCl targets the chemokine receptors CXCR, which are part of the GPCR family.
Molecular Formula
C21H30Cl3N5
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AMD-070 HCl can be used to investigate its antagonistic effects on the CXCR4 receptor in HIV/AIDS and cancer research.
Related Products
